Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Europe: 4 Urban communities for a Paramount Social Experience05.06.2024 - 2Indian rocket launches record-breaking BlueBird 6 smartphone satellite to orbit (video)23.12.2025
- 3Revealing the Incomparable Realms: An Excursion through Power and Inheritance30.06.2023
- 4Watch interstellar comet 3I/ATLAS speed away from the sun in free telescope livestream on Nov. 1616.11.2025
- 5Experience Is standing by: 10 Pleasant Setting up camp Areas to05.06.2024
- Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
- Best Amusement Park Bite: What Do You Very much want to Crunch On?
- The Main 20 Gaming Control center Ever
- BravoCon 2025: How to watch, full schedule and lineup, where to stream free and more
- Without evidence, CDC changes messaging on vaccines and autism
- Aspirin can prevent a serious pregnancy complication — but too few women get it, new report suggests
- The most effective method to Plan an Incineration Administration: A Bit by bit Guide.
- The most effective method to Pick the Right Teeth Substitution Choice for You
- Lucrative Positions in the Advancing Position Market of 2024
